Reduction of lymph nodes metastases and serum tumour markers have also been reported in a BM-CUP (positive for Napsin A, TTF-1, and EGFR exon 19 deletion) treated with the EGFR-TKI gefitinib [74]. This evidence concerns the gene NAPSA and neoplasm.